The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 365.00
Bid: 360.00
Ask: 380.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.556%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 365.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Dealings - Replacement

23 Nov 2017 07:00

RNS Number : 2905X
Focusrite PLC
22 November 2017
 

The following amendment has been made to the Director Share Dealings announcement released on 22 November 2017 at 14:50 under RNS No 2617X.

In the second paragraph the resultant aggregate holdings for Mr Carroll and Mr Wilson should have been 4,750 and 45,971 Ordinary Shares respectively.

In 4d for Mr Carroll the Aggregated price of shares acquired should have been £ 28,665.63

All other details remain unchanged.

The full amended text is shown below.

Focusrite Plc

 

("the Company" or "the Group")

 

Focusrite Plc FY17 Discretionary Director Bonus (FY17 Bonus)

Director Share Dealings

 

Focusrite Plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 22 November 2017 it issued 9,173 ordinary shares of 0.1p each in the capital of the Company ("Ordinary Shares") to Tim Carroll (CEO of the Company) and 27,466 Ordinary Shares to Jeremy Wilson (CFO of the Company) subject only to admission of such shares to trading on AIM ("Admission"). Accordingly, application has been made for 36,639 Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will occur on 28 November 2017. The new Ordinary Shares will rank pari-passu with the existing Ordinary Shares.

 

A proportion of these shares has been sold to settle the resultant income tax and national insurance liabilities. Consequently, Mr Carroll holds an aggregate of 4,750 Ordinary Shares, representing approximately 0.008 per cent of the Company's enlarged ordinary share capital and Mr Wilson holds an aggregate of 45,971 Ordinary Shares, representing approximately 0.079 per cent of the Company's enlarged ordinary share capital. Following Admission, the Company's issued share capital will comprise 58,111,639 Ordinary Shares, of which no Ordinary Shares are held in treasury. The total number of current voting rights in the Company following Admission will therefore be 58,111,639 Ordinary Shares.

 

The above figure of 58,111,639 may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Number of Ordinary Shares

Director

Ordinary Shares issued under the FY17 Bonus

Ordinary Shares sold to satisfy tax liabilities

Retained

Tim Carroll

9,173

4,423

4,750

Jeremy Wilson

27,466

13,241

14,225

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Tim Carroll

 

2

Reason for the notification

a)

Position/status

 classified as PDMR of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

· 1. Shares acquired

· 2. Shares sold to satisfy tax liabilities

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Volumes Sold

1) 0.1p

2) 307p

9,173

-

-

4,423

d)

Aggregated information

- Aggregated volume 

- Price 

Aggregated price of shares acquired: £ 28,665.63

Aggregated price of shares sold: £ 13,578.61

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

London Stock Exchange - XLON

 

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Jeremy Wilson

2

Reason for the notification

a)

Position/status

 classified as PDMR of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

· 1. Shares acquired

· 2. Shares sold to satisfy tax liabilities

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Volumes Sold

1) 0.1p

2) 307p

27,466

-

-

13,241

d)

Aggregated information

- Aggregated volume 

- Price 

Aggregated price of shares acquired: £ 85,831.25

Aggregated price of shares sold: £ 40,649.87

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

London Stock Exchange - XLON

 

 

-ends-

 

Enquiries:

 

Focusrite Plc:

David Bezem (Non-executive Director and Remuneration Committee Chairman)

+44 1494 462246

Mike Warriner (General Counsel)

+44 1494 462246

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBTBMTMBTTTAR
Date   Source Headline
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement
8th Jan 20244:36 pmRNSTR-1
2nd Jan 20247:00 amRNSPHIL DUDDERIDGE AWARDED OBE
19th Dec 20237:00 amRNSAcquisition of Sheriff Technology Limited
7th Dec 20233:58 pmRNSTR-1
5th Dec 20232:02 pmRNSGrant of Share Options to PDMRs
5th Dec 20231:54 pmRNSDirector Share Dealings
29th Nov 20234:51 pmRNSTR-1
28th Nov 20237:00 amRNSFinal Results
17th Nov 202310:27 amRNSTR-1
17th Nov 20237:00 amRNSTR-1
7th Nov 20237:00 amRNSTR-1
31st Oct 20237:00 amRNSNotice of Final Results
14th Sep 20237:00 amRNSTrading Update for the year ended 31 August 2023
9th Jun 202310:54 amRNSNotification of PDMR Transactions
16th May 20237:20 amRNSChange of Registered Office
3rd May 20237:00 amRNSPDMR Dealings
26th Apr 20232:39 pmRNSInterim Dividend Timetable Correction
25th Apr 20237:00 amRNSHalf year results
11th Apr 20231:28 pmRNSNotice of Interim Results
14th Mar 20237:00 amRNSTrading Update
22nd Feb 20239:25 amRNSNotification of PDMR Transactions
7th Feb 20239:51 amRNSPDMR Dealings
3rd Feb 202312:49 pmRNSResult of AGM
3rd Feb 20237:00 amRNSAGM Statement and Update on Trading
18th Jan 20237:00 amRNSSettlement of Share Options
18th Jan 20237:00 amRNSNotification of PDMR Transaction
16th Jan 202311:43 amRNSSettlement of Share Options
22nd Dec 202211:49 amRNSGrant of Share Options to PDMRs
20th Dec 20227:00 amRNSAcquisition of Sonnox Limited
14th Dec 20227:00 amRNSPDMR
8th Dec 20229:05 amRNSSecond Price Monitoring Extn
8th Dec 20229:00 amRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSFinal Results
7th Dec 202211:12 amRNSShare issuance to Employee Benefit Trust
21st Nov 20227:00 amRNSChange to Final Results announcement date
7th Nov 20227:00 amRNSNotice of Final Results
27th Oct 20221:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.